Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Beatriz Rodriguez-Sanchez, Isaac Aranda-Reneo, Juan Oliva-Moreno & Julio Lopez-Bastida. (2021) Assessing the Effect of Including Social Costs in Economic Evaluations of Diabetes-Related Interventions: A Systematic Review. ClinicoEconomics and Outcomes Research 13, pages 307-334.
Read now
Read now
Gaurav Deshpande, Andrew J. Klink, Rahul Shenolikar, Joseph Singer, Debra F. Eisenberg Lawrence & Girishanthy Krishnarajah. (2016) Economic burden of hepatitis B infection among patients with diabetes. Human Vaccines & Immunotherapeutics 12:5, pages 1132-1140.
Read now
Read now
Florian Kirsch. (2015) A systematic review of Markov models evaluating multicomponent disease management programs in diabetes. Expert Review of Pharmacoeconomics & Outcomes Research 15:6, pages 961-984.
Read now
Read now
Anna O. D'Souza, Manan Shah, Amol D. Dhamane & Anand A. Dalal. (2014) Clinical and Economic Burden of COPD in a Medicaid Population. COPD: Journal of Chronic Obstructive Pulmonary Disease 11:2, pages 212-220.
Read now
Read now
Katharina Eckert. (2012) Impact of physical activity and bodyweight on health-related quality of life in people with type 2 diabetes. Diabetes, Metabolic Syndrome and Obesity 5, pages 303-311.
Read now
Read now
Articles from other publishers (24)
Haechung ChungChristopher L CroweSheldon X KongRakesh SinghRyan FarejJay ElliottTodd WilliamsonVincent J Willey. (2023) Descriptive study of the economic burden among patients with type 2 diabetes mellitus, chronic kidney disease, and chronic kidney disease and type 2 diabetes mellitus in a large US commercially insured population. Journal of Managed Care & Specialty Pharmacy 29:1, pages 80-89.
Crossref
Crossref
Muhammad Shoaib Farooq, Shamyla Riaz, Rabia Tehseen, Uzma Farooq & Khalid Saleem. (2023) Role of Internet of things in diabetes healthcare: Network infrastructure, taxonomy, challenges, and security model. DIGITAL HEALTH 9, pages 205520762311790.
Crossref
Crossref
Tsung‐Ying Lee, Shihchen Kuo, Chen‐Yi Yang & Huang‐Tz Ou. (2020)
Cost‐effectiveness of long‐acting insulin analogues
vs
intermediate/long‐acting human insulin for type 1 diabetes: A population‐based cohort followed over 10 years
. British Journal of Clinical Pharmacology 86:5, pages 852-860.
Crossref
Crossref
Mehmet Top, Hüseyin Aslan, Çağdaş Erkan Akyürek & Emine Çetin Aslan. (2020) Costs analysis of diabetes mellitus: A study based on hospital invoices and diagnosis related groups. Health Policy and Technology 9:1, pages 23-31.
Crossref
Crossref
Afsana Afroz, Mohammed J. Alramadan, Md Nassif Hossain, Lorena Romero, Khurshid Alam, Dianna J. Magliano & Baki Billah. (2018) Cost-of-illness of type 2 diabetes mellitus in low and lower-middle income countries: a systematic review. BMC Health Services Research 18:1.
Crossref
Crossref
R. De Giglio, I. Stefani, T. Mondello, G. De Filippis & A. Mazzone. (2018) BIOACTIVE GLASS S53P4: a new opportunity for the treatment in the diabetic foot osteomyelitis. European Journal of Internal Medicine 54, pages e15-e16.
Crossref
Crossref
May Ee Png, Joanne Yoong, Chuen Seng Tan & Kee Seng Chia. (2018) Excess Hospitalization Expenses Attributable to Type 2 Diabetes Mellitus in Singapore. Value in Health Regional Issues 15, pages 106-111.
Crossref
Crossref
Asrul Akmal Shafie, Yui Ping Tan & Chin Hui Ng. (2017) Systematic review of economic burden of heart failure. Heart Failure Reviews 23:1, pages 131-145.
Crossref
Crossref
Natalie Stein & Kevin Brooks. (2017) A Fully Automated Conversational Artificial Intelligence for Weight Loss: Longitudinal Observational Study Among Overweight and Obese Adults. JMIR Diabetes 2:2, pages e28.
Crossref
Crossref
Christian Bommer, Esther Heesemann, Vera Sagalova, Jennifer Manne-Goehler, Rifat Atun, Till B?rnighausen & Sebastian Vollmer. (2017) The global economic burden of diabetes in adults aged 20?79 years: a cost-of-illness study. The Lancet Diabetes & Endocrinology 5:6, pages 423-430.
Crossref
Crossref
Xiaoyuan Bao, Chao Yang, Kai Fang, Moye Shi, Guopei Yu & Yonghua Hu. (2016) Hospitalization costs and complications in hospitalized patients with type 2 diabetes mellitus in Beijing, China. Journal of Diabetes 9:4, pages 405-411.
Crossref
Crossref
Haruhisa Fukuda, Shunya Ikeda, Takeru Shiroiwa & Takashi Fukuda. (2016) The Effects of Diagnostic Definitions in Claims Data on Healthcare Cost Estimates: Evidence from a Large-Scale Panel Data Analysis of Diabetes Care in Japan. PharmacoEconomics 34:10, pages 1005-1014.
Crossref
Crossref
C. Sortsø, A. Green, P. B. Jensen & M. Emneus. (2015) Societal costs of diabetes mellitus in Denmark. Diabetic Medicine 33:7, pages 877-885.
Crossref
Crossref
Yutian Yin, Weiqing Han, Yuhan Wang, Yue Zhang, Shili Wu, Huiping Zhang, Lingling Jiang, Rui Wang, Peng Zhang, Yaqin Yu & Bo Li. (2015) Identification of Risk Factors Affecting Impaired Fasting Glucose and Diabetes in Adult Patients from Northeast China. International Journal of Environmental Research and Public Health 12:10, pages 12662-12678.
Crossref
Crossref
Till Seuring, Olga Archangelidi & Marc Suhrcke. (2015) The Economic Costs of Type 2 Diabetes: A Global Systematic Review. PharmacoEconomics 33:8, pages 811-831.
Crossref
Crossref
Taulant Muka, David Imo, Loes Jaspers, Veronica Colpani, Layal Chaker, Sven J. van der Lee, Shanthi Mendis, Rajiv Chowdhury, Wichor M. Bramer, Abby Falla, Raha Pazoki & Oscar H. Franco. (2015) The global impact of non-communicable diseases on healthcare spending and national income: a systematic review. European Journal of Epidemiology 30:4, pages 251-277.
Crossref
Crossref
Charmaine Shuyu Ng, Matthias Paul Han Sim Toh, Yu Ko & Joyce Yu-Chia Lee. (2015) Direct Medical Cost of Type 2 Diabetes in Singapore. PLOS ONE 10:3, pages e0122795.
Crossref
Crossref
Ping Cao, Kaixiu Wang, Hua Zhang, Rongzhi Zhao & Chenglong Li. (2015) Factors Influencing the Hospitalization Costs of Patients With Type 2 Diabetes. Asia Pacific Journal of Public Health 27:2_suppl, pages 55S-60S.
Crossref
Crossref
Mary E. CostantinoJane N. StacyFrank SongYihua XuJonathan R. Bouchard. (2014) The Burden of Diabetes Mellitus for Medicare Beneficiaries. Population Health Management 17:5, pages 272-278.
Crossref
Crossref
Charmaine S. Ng, Joyce Y.C. Lee, Matthias PHS Toh & Yu Ko. (2014) Cost-of-illness studies of diabetes mellitus: A systematic review. Diabetes Research and Clinical Practice 105:2, pages 151-163.
Crossref
Crossref
R. Brett McQueen, Samuel L. Ellis, David M. Maahs, Heather D. Anderson, Kavita V. Nair, Anne M. Libby & Jonathan D. Campbell. (2014) Association Between Glycated Hemoglobin and Health Utility for Type 1 Diabetes. The Patient - Patient-Centered Outcomes Research 7:2, pages 197-205.
Crossref
Crossref
Jason Yeaw, Shawn Halinan, Dionne Hines, Amy DeLozier, Magaly Perez, Mark Boye, Kristina Secnik Boye & Christopher M. Blanchette. (2014) Direct Medical Costs for Complications Among Children and Adults with Diabetes in the US Commercial Payer Setting. Applied Health Economics and Health Policy 12:2, pages 219-230.
Crossref
Crossref
Cai Le, Li Lin, Dong Jun, He Jianhui, Zhao Keying, Cui Wenlong, Song Ying & Wei Tao. (2013) The economic burden of type 2 diabetes mellitus in rural southwest China. International Journal of Cardiology 165:2, pages 273-277.
Crossref
Crossref
Javier Soto ÁlvarezJavier Soto Álvarez. 2012. Evaluación económica de medicamentos y tecnologías sanitarias:. Evaluación económica de medicamentos y tecnologías sanitarias:
63
74
.